Literature DB >> 15655837

Metastasis of primary gallbladder carcinoma in lymph node and liver.

Han-Ting Lin1, Gui-Jie Liu, Dan Wu, Jian-Ying Lou.   

Abstract

AIM: To evaluate the patterns with metastasis of gallbladder carcinoma in lymph nodes and liver.
METHODS: A total of 45 patients who had radical surgery were selected. The patterns with metastasis of primary gallbladder carcinoma in lymph nodes and liver were examined histopathologically and classified as TNM staging of the American Joint Committee on Cancer.
RESULTS: Of the 45 patients, 29 (64.4%) had a lymph node positive disease and 20 (44.4%) had a direct invasion of the liver. The frequency of involvement of lymph nodes was strongly influenced by the depth of the primary tumor (P = 0.0001). The postoperative survival rate of patients with negative lymph node metastasis was significantly higher than that of patients with positive lymph node metastasis (P = 0.004), but the postoperative survival rate of patients with N1 lymph node metastasis was not significantly different from that of patients with N2 lymph node metastasis (P = 0.3874). The postoperative survival rate of patients without hepatic invasion was significantly better than that of patients with hepatic invasion (P = 0.0177).
CONCLUSION: Complete resection of the regional lymph nodes is important in advanced primary gallbladder carcinoma (PGC). The initial sites of liver spread are located mostly in segments IV and V. It is necessary to achieve negative surgical margins 2 cm from the tumor. In patients with hepatic hilum invasion, extended right hepatectomy with or without bile duct resection or portal vein resection is necessary for curative resection.

Entities:  

Mesh:

Year:  2005        PMID: 15655837      PMCID: PMC4250754          DOI: 10.3748/wjg.v11.i5.748

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Early gallbladder carcinoma does not warrant radical resection.

Authors:  T Wakai; Y Shirai; N Yokoyama; S Nagakura; H Watanabe; K Hatakeyama
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

2.  Factors affecting surgical outcome for gallbladder carcinoma.

Authors:  Hirokazu Noshiro; Kazuo Chijiiwa; Koji Yamaguchi; Syuji Shimizu; Atsushi Sugitani; Masao Tanaka
Journal:  Hepatogastroenterology       Date:  2003 Jul-Aug

3.  Identification of the regional lymphatic system of the gallbladder by vital staining.

Authors:  Y Shirai; K Yoshida; K Tsukada; T Ohtani; T Muto
Journal:  Br J Surg       Date:  1992-07       Impact factor: 6.939

4.  Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection.

Authors:  H Shimada; I Endo; Y Fujii; N Kamiya; H Masunari; O Kunihiro; K Tanaka; K Misuta; S Togo
Journal:  Langenbecks Arch Surg       Date:  2000-12       Impact factor: 3.445

5.  Anatomy and clinical importance of cholecystic venous drainage: helical CT observations during injection of contrast medium into the cholecystic artery.

Authors:  K Yoshimitsu; H Honda; K Kaneko; T Kuroiwa; H Irie; K Chijiiwa; K Takenaka; K Masuda
Journal:  AJR Am J Roentgenol       Date:  1997-08       Impact factor: 3.959

6.  Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma.

Authors:  S Kondo; Y Nimura; N Hayakawa; J Kamiya; M Nagino; K Uesaka
Journal:  Br J Surg       Date:  2000-04       Impact factor: 6.939

7.  Lymph node spread from carcinoma of the gallbladder.

Authors:  K Tsukada; I Kurosaki; K Uchida; Y Shirai; Y Oohashi; N Yokoyama; H Watanabe; K Hatakeyama
Journal:  Cancer       Date:  1997-08-15       Impact factor: 6.860

8.  Spread of gallbladder carcinoma: CT evaluation with pathologic correlation.

Authors:  T Ohtani; Y Shirai; K Tsukada; T Muto; K Hatakeyama
Journal:  Abdom Imaging       Date:  1996 May-Jun

9.  Routes of hepatic metastasis of gallbladder carcinoma.

Authors:  M Ohtsuka; M Miyazaki; H Itoh; K Nakagawa; S Ambiru; H Shimizu; N Nakajima; B Akikusa; Y Kondo
Journal:  Am J Clin Pathol       Date:  1998-01       Impact factor: 2.493

10.  Hepatic metastases from carcinoma of the gallbladder.

Authors:  Y Shirai; K Tsukada; T Ohtani; H Watanabe; K Hatakeyama
Journal:  Cancer       Date:  1995-04-15       Impact factor: 6.860

View more
  7 in total

Review 1.  Gallbladder cancer, treatment failure and relapses: the peritoneum in gallbladder cancer.

Authors:  Charlotte Maplanka
Journal:  J Gastrointest Cancer       Date:  2014-09

Review 2.  Modern perspectives on factors predisposing to the development of gallbladder cancer.

Authors:  Charles H C Pilgrim; Ryan T Groeschl; Kathleen K Christians; T Clark Gamblin
Journal:  HPB (Oxford)       Date:  2013-01-18       Impact factor: 3.647

3.  Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis.

Authors:  Gui-Jie Liu; Xue-Hua Li; Yan-Xin Chen; Hui-Dong Sun; Gui-Mei Zhao; San-Yuan Hu
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

4.  Positive relationship between number of negative lymph nodes and duration of gallbladder cancer cause-specific survival after surgery.

Authors:  Jin-Yong Lin; Dou-Sheng Bai; Bao-Huan Zhou; Ping Chen; Jian-Jun Qian; Sheng-Jie Jin; Guo-Qing Jiang
Journal:  Cancer Manag Res       Date:  2018-12-13       Impact factor: 3.989

5.  FDG PET-MRI evaluation of synchronous gallbladder adenocarcinoma and POEMS syndrome.

Authors:  Fatemeh Ataei; Akash Sharma; Rupert Stanborough; Ephraim E Parent
Journal:  Radiol Case Rep       Date:  2022-09-13

Review 6.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

7.  Prognostic impact of tumor location in resected gallbladder cancer: A national cohort analysis.

Authors:  Kelly Lafaro; Andrew M Blakely; Laleh G Melstrom; Susanne G Warner; Byrne Lee; Gagandeep Singh; Yuman Fong; Mustafa Raoof
Journal:  J Surg Oncol       Date:  2020-07-11       Impact factor: 2.885

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.